ARCHIVES

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 19 No. 04 | January 22, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: ACCC Celebrates 25th: James Hospital Receives Large Donations

April 9, 1999

Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT

April 29, 1994

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

What the Physician Pay Report Won’t Tell You

April 11, 2014